Immunowake Patents – Insights & Stats (Updated 2023)

Immunowake has a total of 28 patents globally. Of these 28 patents, more than 82% patents are active. Canada is where Immunowake has filed the maximum number of patents, followed by Australia, China and United States of America. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Immunowake.

Immunowake is was founded in the year 2019. Immunowake is a biotechnology company that focuses on finding novel treatments for patients who don’t react to current immunotherapies. Using the body’s immune system to recognize and eliminate cancer cells in a manner similar to how pathogens are recognized and eliminated is known as immunotherapy.

Do read about some of the most popular patents of Immunowake which have been covered by us in this article and also you can find Immunowake patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Immunowake patent portfolio.

How many patents does Immunowake have?

Immunowake has a total of 28 patents globally. These patents belong to 5 unique patent families. Out of 28 patents, 23 patents are active.

How Many Patents did Immunowake File Every Year?

Immunowake Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantImmunowake Applications FiledImmunowake Patents Granted

How many Immunowake patents are Alive/Dead?

Worldwide Patents

Immunowake Patent Portfolio

How Many Patents did Immunowake File in Different Countries?

Immunowake Worldwide Patent Filing

Countries in which Immunowake Filed Patents

United States Of America3
Hong Kong (S.A.R.)2
South Africa2
New Zealand1

Where are Research Centers of Immunowake Patents Located?

R&D Centres of Immunowake

Best Immunowake Patents

CN111372950A is the most popular patent in the Immunowake portfolio. It has received 3 citations so far from companies like Dansheng Pharmaceutical Technology (Shanghai), Sansheng Guojian Pharmaceutical (Shanghai), Hangzhou Hansi Biopharmaceutical.

What Percentage of Immunowake US Patent Applications were Granted?

Immunowake (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Immunowake patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Immunowake?

Law FirmTotal ApplicationsSuccess Rate
Morrison & Foerster Llp20%

List of Immunowake Patents

Immunowake PatentsTitle
US20230167164A1Immunocytokines And Uses Thereof
US20220291203A1Methods Of Measuring Cell-Mediated Killing By Effectors
US20200325208A1Vegfr-Antibody Light Chain Fusion Protein
EP4263836A1Immunocytokines And Uses Thereof
EP3694890A4Vegfr-Antibody Light Chain Fusion Protein
CN116806224AImmune Cytokines And Their Uses
CN114787373AMethod Of Measuring Cell-Mediated Killing By Effector
CN111372950AVegfr-Antibody Light Chain Fusion Protein
CA3211581A1Immunomodulatory Molecules And Uses Thereof
CA3203239A1Immunocytokines And Uses Thereof
CA3185107A1Vegfr-Antibody Light Chain Fusion Protein
AU2022232951A1Immunomodulatory Molecules And Uses Thereof
AU2021410089A1Immunocytokines And Uses Thereof
AU2018347521A1Vegfr-Antibody Light Chain Fusion Protein
HK40077368AMethods Of Measuring Cell-Mediated Killing By Effectors
HK40035996AVegfr-Antibody Light Chain Fusion Protein
ZA202309430AImmunomodulatory Molecules And Uses Thereof
MX2023007607AImmunocytocins And Uses Of These
IL303967AImmunocytokines And Uses Thereof
SG11202304759WAImmunocytokines And Uses Thereof
ZA202307146AImmunocytokines And Uses Thereof
BR112023012271A2Immunocytokin, Methods For Selectively Activating The Activity Of A Cytokine Or Variant Thereof, For Producing An Immunocytokin, For Treat A Disease Or Disorders In A Subject And For Preventing Cancer, Isolated Nucleic Acid, Vector, Isolated Host Cell, Pharmaceutical Composition, And , Cancer Vaccine
NZ802028AImmunocytokines And Uses Thereof
WO2022192898A3Immunomodulatory Molecules And Uses Thereof
WO2022140797A1Immunocytokines And Uses Thereof
WO2021016598A1Methods Of Measuring Cell-Mediated Killing By Effectors
CA3078974A1Vegfr-Antibody Light Chain Fusion Protein
IL273749AVegfr-Antibody Light Chain Fusion Protein

What are Immunowake key innovation segments?

What Technologies are Covered by Immunowake?

The chart below distributes patents filed by Immunowake in different countries on the basis of the technology protected in patents. It also represents the markets where Immunowake thinks it’s important to protect particular technology inventions.

R&D Focus: How has Immunowake search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Immunowake?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.